Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is PT Famon Awal Bros Sedaya Tbk EV-to-EBITDA?
PT Famon Awal Bros Sedaya TbkISX:PRAY 90 EV-to-EBITDA is 30.34 as of Aug. 12, 2026, which is 8% below its 10-year median of 32.92. GuruFocus rates ISX:PRAY with a GF Score™ of 90/100 and a GF Value™ of Rp895.27 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 513 Healthcare Providers & Services companies, PT Famon Awal Bros Sedaya Tbk ranks worse than 85.96% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PT Famon Awal Bros Sedaya Tbk's enterprise value is Rp11,981,129 Mil.
PT Famon Awal Bros Sedaya Tbk's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was Rp394,896 Mil. Therefore, PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA for today is 30.34.
The historical rank and industry rank for PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA or its related term are showing as below:
ISX:PRAY'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 21.76 Med: 32.92 Max: 82.96
Current: 30.34
During the past 7 years, the highest EV-to-EBITDA of PT Famon Awal Bros Sedaya Tbk was 82.96. The lowest was 21.76. And the median was 32.92.
ISX:PRAY's EV-to-EBITDA is ranked worse than 85.96% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.81
vs ISX:PRAY: 30.34
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Famon Awal Bros Sedaya Tbk's PE Ratio (TTM) for today is calculated as:
PT Famon Awal Bros Sedaya Tbk's share price for today is Rp740.00.
PT Famon Awal Bros Sedaya Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp13.242.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PRAY vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Famon Awal Bros Sedaya Tbk EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA falls into.
PT Famon Awal Bros Sedaya Tbk's current Enterprise Value is Rp11,981,129 Mil.
PT Famon Awal Bros Sedaya Tbk's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp394,896 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) has a EV-to-EBITDA of 30.34 as of Aug. 12, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PT Famon Awal Bros Sedaya Tbk. This is near median its historical median of 32.92. Over the past decade, PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA has ranged from 21.76 to 82.96. According to the industry distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #441 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 86%.
Is PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA too high?
PT Famon Awal Bros Sedaya Tbk's current EV-to-EBITDA of 30.34 is near median its 10-year median of 32.92. Over the past 10 years, this metric has ranged from a low of 21.76 to a high of 82.96. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.81. PT Famon Awal Bros Sedaya Tbk's value of 30.34 is 180.7% above this industry median. Based on the distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #441 out of 513 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Famon Awal Bros Sedaya Tbk has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Famon Awal Bros Sedaya Tbk's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Famon Awal Bros Sedaya Tbk ranks #441 out of 513 companies for EV-to-EBITDA. This places PT Famon Awal Bros Sedaya Tbk in the lower half of its industry. The industry median EV-to-EBITDA is 10.81. PT Famon Awal Bros Sedaya Tbk's value of 30.34 is 180.7% above this benchmark. Historically, PT Famon Awal Bros Sedaya Tbk's own EV-to-EBITDA has ranged from 21.76 to 82.96 over the past decade. While the company's 10-year median is 32.92 vs. the industry median of 10.81, PT Famon Awal Bros Sedaya Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.81, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Famon Awal Bros Sedaya Tbk's current EV-to-EBITDA of 30.34 is 180.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PT Famon Awal Bros Sedaya Tbk. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Famon Awal Bros Sedaya Tbk's current EV-to-EBITDA is 30.34, which is near median its own 10-year median of 32.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Famon Awal Bros Sedaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp895.27, compared to a current price of Rp740.00 — trading 17.3% below its estimated fair value. The current EV-to-EBITDA is 30.34, which is near median its 10-year median of 32.92 and 180.7% above the Healthcare Providers & Services industry median of 10.81. PT Famon Awal Bros Sedaya Tbk's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PT Famon Awal Bros Sedaya Tbk (ISX:PRAY), the current EV-to-EBITDA is 30.34 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Famon Awal Bros Sedaya Tbk (ISX:PRAY) Overvalued in 2026?
Based on GuruFocus' analysis, PT Famon Awal Bros Sedaya Tbk stock appears to be undervalued.
The current stock price of Rp740.00 is trading 17.3% below its estimated GF Value™ of Rp895.27.
GuruFocus considers PT Famon Awal Bros Sedaya Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PRAY:
EV-to-EBITDA: 30.34 (near median its 10-year median of 32.92)
GF Value™: Rp895.27 vs. price of Rp740.00 (17.3% below fair value)
Industry Position: 180.7% above the Healthcare Providers & Services median (#441 of 513)
No single metric tells the full story. See the ISX:PRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Famon Awal Bros Sedaya Tbk operates as a hospital. The company7 provides comprehensive health services for Indonesians and foreign nationals (foreigners) and provides patient services with guarantees from companies, insurance, BPJS, and personal payments. Its hospital network has spread across different cities in Indonesia, including Jakarta, Bekasi, Tangerang, Semarang, Sukabumi, Makassar, Palangkaraya, and Pangkal Pinang. The services that it provides for patients include heart and blood vessel service centers, mother and child services, sports clinic & orthopedic services, cancer services, eye care centers & urology centers. The company's segments are Java; Kalimantan dan/ and Sulawesi; and Sumatera. It derives maximum revenue from Jawa.
90GF Score
Get the complete analysis for ISX:PRAY
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRAY has been successfully added to your 
